FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20566311000001106: Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69255701000001113 Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70047501000001116 Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet 2 x 15 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Is a Repaglinide 500microgram tablets 30 tablet true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Has AMP Repaglinide 500microgram tablets (Creo Pharma Ltd) true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Has specific active ingredient Repaglinide true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start